Oral contraceptive failures among women terminating their pregnancy

References

• Trussel J, Kost K. Contraceptive failure in the United States: A critical review of the literature. Stud Fam Plann 1987; 18: 237–83.
   Google Scholar
• Andersson K, Odlind V Rybo G. Levonorgestrel-releasing and copper-releasing (NOVA-T) IUDs during five years of use: A randomized comparative trial. Contraception 1994; 49: 56–72.
   Google Scholar
• Woutersz TB, Korba VD. Five-year, multicenter study of a triphasic low-dose, combination oral contraceptive. Int J Fertil 1988; 33: 406–10.
   Google Scholar
• Rekers H. Multicentre trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel. Acta Obstet Gynecol Scand 1988; 67: 171–4.
   Google Scholar
• Speroff L, DeCherney A. Evaluation of a new generation or oral contraceptives. Obstet Gynecol 1993; 81: 1034–47.
   Google Scholar
• Moloy BG, Coulson KA, Lee JM, Watters JK. ‘Missed pill’ conception: fact or fiction? BMJ 1985; 290: 1474–5.
   Google Scholar
• Killick S, Eyong E, Elstein M. Ovarian follicular development in oral contraceptive cycles. Fertil Steril 1987; 48: 409–13.
   Google Scholar
• Hamilton CJCM, Hoogland HJ. Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect use. Am J Obstet Gynecol 1989; 161: 1159–62.
   Google Scholar
• Young, RL, Snabes MC, Frank ML, Reilly M. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development. Am J Gynecol Obstet 1992; 167: 678–82.
   Google Scholar
• Grimes DA, Godwin AJ, Rubin A, Smith JA, Lacarra M. Ovulation and follicular development associated with three low-dose oral contraceptives: A randomized controlled trial. Obstet Gynecol 1994; 83: 29–34.
   Google Scholar
• Letterie GS, Chow GE. Effect of ‘missed’ pills on oral contraceptive effectiveness. Obstet Gynecol 1992; 79: 979–82.
   Google Scholar
• Skjeldestad FE. Avgjerdsprosessen og behov for informasjon blant abortsokande kvinner. Tidsskr Nor Lægeforen 1994; 114: 2276–9. (in Norwegian; English summary: The decision-making process and need for medical information among women seeking abortion in 1983 and 1993).
   Google Scholar
• Skjeldestad FE. Choice of contraceptive modality by women in Norway. Acta Obstet Gynecol Scand 1994; 73: 48–52.
   Google Scholar
• Noack T, Østby L. Mer effektiv prevensjonsbruk. Samfunnsspeilet 1991; 5: 20–4. (In Norwegian: More effecive use of contraception).
   Google Scholar
• Skjeldestad FE, Borgan J-K, Daltveit AK, Nymoen EH. Induced abortion. Effects of marital status, age and parity on choice of pregnancy termination. Acta Obstet Gynecol Scand 1994; 73: 255–60.
   Google Scholar
• Skjeldestad FE. The incidence of repeat induced abortion – a prospective cohort study. Acta Obstet Gynecol Scand 1994; 73: 706–10.
   Google Scholar
• Griffiths M. Contraceptive practices and contraceptive failures among women requesting termination of pregnancy. Br J Fam Plann 1990; 16: 16–18.
   Google Scholar
• Population Statistics 1996. Volume II, Population 1, January. Statistics Norway. Oslo/Kongsvinger 1996.
   Google Scholar
• Ketting E. The relative reliability of oral contraceptives: Findings of an epidemiological study. Contraception 1988; 7: 43–8.
   Google Scholar
• Kovacs GT, Riddoch G, Duncombe P et al. Inadvertent pregnancies in oral contraceptive users. Med J Aust 1989; 150: 549–51.
   Google Scholar
• UK Committee on Safety of Medicine, Letter, 18 October, 1995.
   Google Scholar
• Skjeldestad FE. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives. Contraception 1997; 55: 11–14.
   Google Scholar
• Rygh L. Tvilsomt om Marvelon-saken forte til p-pillefrykt. In: Nytt om legemidler 1997; 20: 4. (In: News from the Norwegian Medicines Control Agency; in Norwegian: (There is doubt whether the case of Marvelon resulted in any OC-scare in Norway.)
   Google Scholar
• Henshaw SK, Silverman J. The characteristics of prior contraceptive use of US abortion patients. Fam Plann Perspect 1988; 20: 158–68.
   Google Scholar
• World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582–8.
   Google Scholar
• Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 158993.
   Google Scholar